In mice, a population of CD11b+Gr1+ monocytes and their macrophage progeny have a central function in tumour resistance to VEGF-based anti-angiogenic therapy, suppression of anti-tumour immunity and metastasis2. The gene discussed is ITGAM; the disease is neoplasm.